Progesterone-induced secretion of growth hormone, insulin-like growth factor I and prolactin by human breast cancer explants

Gynecological Endocrinology

Volumn 15, Issue 4, 2001, Pages 251-258

  Gregoraszczuk, E L ^a   Milewicz, T ^b   Kolodziejczyk, J ^a   Krzysiek, J ^b   Basta, A ^b   Sztefko, K ^b   Kurek, S ^b   Stachura, J ^b  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Growth hormone; Human breast cancer; IGF I; In vitro; Progesterone; Prolactin

Indexed keywords

ESTROGEN RECEPTOR; GROWTH HORMONE; PROGESTERONE; PROGESTERONE RECEPTOR; PROLACTIN; SOMATOMEDIN C;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; EXPLANT; FEMALE; GROWTH HORMONE RELEASE; HORMONE RELEASE; HUMAN; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL;

EID: 0034855062     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/gye.15.4.251.258     Document Type: Article

References (35)

1. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk
2. Biology of female sex hormone action in relation to contraceptive agents and neoplasia
3. The molecular biology of RU486. Is there a role for antiprogestins in treatment of breast cancer?
4. Epidemiologic aspects of exogenous progestogens in relation to their role in pathogenesis of human breast cancer
5. Effects of sex steroids on proliferation in normal mammary tissue
6. Inhibition by nomegestrol acetate and other synthetic progesterone proliferation and progesterone receptor content of T47-D human breast cancer cells
7. Progesterone metabolism in T47Dco human breast cancer cells - II Intracellular metabolic path of progesterone and synthetic progestins
8. The 4-pregnen and 5 alpha-pregnane progesterone metabolites formed in nontumorous and tumorous breast tissue have opposite effects on breast cell proliferation and adhesion
9. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk
10. Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin
11. 17-Beta hydroxysteroid oxidoreductase activity in intact cell significantly differs from classical enzymatology analysis
12. Growth hormone mRNA in mammary gland tumours of dogs and cats
13. Growth hormone, prolactin and cortisol in dogs developing mammary nodules and an acromegalic-like appearance during treatment with medroxy-progesterone acetate
14. Acromegaly associated with transient overproduction of growth hormone in a dog
15. Influence of medroxy-progesterone acetate (Provera) on plasma growth hormone levels and on carbohydrate metabolism. I. Studies in the ovary hysterectomized bitch
16. Progestin regulation of cellular proliferation
17. Progestin-induced growth hormone excess in the dog originates in the mammary gland
18. Progestin regulation of insulin and insulin-like growth factor I receptors in cultured human breast cancer tissue
19. Progestins increase insulin receptor content and insulin stimulation of growth in human breast carcinoma tissue
20. The role of progestins, insulin-like growth factor (IGF) and IGF-binding proteins in the normal and neoplastic mammary gland of the bitch: A review
21. New insights in the molecular mechanism of progestin-induced proliferation of mammary epithelium: Induction of the local biosynthesis of growth hormone (GH) in the mammary glands of dogs, cats and humans
22. A case-control study of breast cancer and hormonal contraception in Costa Rica
23. Differential expression of the growth hormone receptor and growth hormone-binding protein in epithelia and stroma of the mouse mammary gland at various physiological stages
24. The role of prolactin and growth hormone in breast cancer
25. Interactions of prolactin and growth hormone (GH) in the regulation of mammary gland function and epithelial cell survival
26. The effect of GH on estrogen receptor expression in the rat mammary gland
27. The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue
28. Repression of the insulin receptor promoter by the tumor suppressor gene product p53: A possible mechanism for receptor overexpression in breast cancer
29. Impact of progesterone receptor on cell-fate decisions during mammary gland development
30. Steroid hormone receptor status and other immunohistochemical prognostic markers in benign and malignant diseases of the breast
31. Convergence of progesterone with growth factor and cytokine signaling in breast cancer. Progesterone receptors regulate signal transducers and activators of transcription expression and activity
32. Extrapituitary prolactin, distribution, regulation, functions, and clinical aspects
33. Prolactin synthesis and secretion by human breast cancer tissue
34. Prognostic significance of prolactin receptors in human breast cancer
35. Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptor in breast cancer